Janney Montgomery Scott’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,862
Closed -$375K 2722
2023
Q3
$375K Buy
11,862
+6,666
+128% +$259K ﹤0.01% 1984
2023
Q2
$212K Sell
5,196
-175
-3% -$7.1K ﹤0.01% 2430
2023
Q1
$200K Buy
+5,371
New +$211K ﹤0.01% 2288
2022
Q4
Sell
-12,691
Closed -$710K 2616
2022
Q3
$710K Buy
12,691
+704
+6% +$43.7K ﹤0.01% 1481
2022
Q2
$624K Sell
11,987
-543
-4% -$27.6K ﹤0.01% 1483
2022
Q1
$911K Buy
12,530
+318
+3% +$26.9K ﹤0.01% 1301
2021
Q4
$1.44M Buy
12,212
+3,509
+40% +$440K 0.01% 1142
2021
Q3
$1.17M Sell
8,703
-451
-5% -$68.3K 0.01% 1204
2021
Q2
$1.48M Sell
9,154
-702
-7% -$54.7K 0.01% 1084
2021
Q1
$791K Buy
9,856
+1,342
+16% +$90.1K ﹤0.01% 1318
2020
Q4
$463K Buy
+8,514
New +$309K ﹤0.01% 1618
2019
Q3
Sell
-32,185
Closed -$527K 2113
2019
Q2
$527K Buy
32,185
+1,202
+4% +$18.9K ﹤0.01% 1404
2019
Q1
$529K Buy
30,983
+1,936
+7% +$28.9K ﹤0.01% 1360
2018
Q4
$396K Sell
29,047
-1
-0% -$19 ﹤0.01% 1418
2018
Q3
$831K Sell
29,048
-1,725
-6% -$50.2K 0.01% 1143
2018
Q2
$842K Sell
30,773
-238
-0.8% -$5.77K 0.01% 1077
2018
Q1
$654K Sell
31,011
-2,442
-7% -$60.1K 0.01% 1184
2017
Q4
$643K Buy
+33,453
New +$772K 0.01% 1179

Other funds holding NTLA

Janney Montgomery Scott's NTLA Position: Q4 2023 in Review

Janney Montgomery Scott sold out of Intellia Therapeutics (NTLA) in Q4 2023, closing a stake of 11,862 shares — an estimated $375K sold.

Janney Montgomery Scott first reported a position in NTLA in Q4 2017 and held it in 18 quarters. The position peaked at $1.48M in Q2 2021. 292 funds tracked by Wall St. Rank hold NTLA as of Q4 2023.

  • Janney Montgomery Scott reported no remaining Intellia Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 11,862 Intellia Therapeutics shares in Q4 2023, an estimated $375K.
  • Janney Montgomery Scott first reported a position in Intellia Therapeutics in Q4 2017 and held it in 18 quarters.
  • Janney Montgomery Scott's Intellia Therapeutics position peaked at $1.48M in Q2 2021.
  • 292 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2023.

Based on Janney Montgomery Scott's 13F filing for Q4 2023, filed 8 Feb 2024.